Claris Biotherapeutics, Inc.
Clinical trials sponsored by Claris Biotherapeutics, Inc., explained in plain language.
-
New eye drops aim to heal corneal scars in just two weeks
Disease control Recruiting nowThis early-stage study tests an experimental eye drop (CSB-001) in 20 people with corneal scars that formed within the last month. Participants use the drops 3-4 times daily for up to 14 days. The main goals are to check safety and see if the drops can reduce scar size and improv…
Phase: PHASE1 • Sponsor: Claris Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:26 UTC
-
New eye drops aim to heal corneas in rare stem cell disorder
Disease control Recruiting nowThis study tests an experimental eye drop called CSB-001 in 75 people with limbal stem cell deficiency, a condition that damages the cornea and can cause vision loss. Participants receive the eye drops in two treatment phases separated by a break, then are observed. The main goal…
Phase: PHASE1 • Sponsor: Claris Biotherapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC